24.07.2013 Views

February 15-18, 2009 Washington State Convention Center Seattle ...

February 15-18, 2009 Washington State Convention Center Seattle ...

February 15-18, 2009 Washington State Convention Center Seattle ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

32<br />

USE OF AQUAFLOR TO CONTROL MORTALITY DUE TO COMMON FISH DISEASES IN<br />

FRESHWATER-REARED SALMONIDS<br />

James D. Bowker<br />

U. S. Fish and Wildlife Service<br />

Aquatic Animal Drug Approval Partnership Program<br />

4050 Bridger Canyon Road<br />

Bozeman, MT 597<strong>15</strong> USA<br />

jim_bowker@fws.gov<br />

Aquaflor ® (50% active florfenicol; Type A medicated feed, sponsor – Schering Plough Animal Health Corporation, Summit NJ)<br />

has recently been approved for use in U. S. aquaculture for the following claims: Administer in feed at a dose of 10 mg florfenicol/kg<br />

fish body weight for 10 consecutive days to control mortality due to (1) enteric septicemia of catfish (causative agent,<br />

Edwardsiella ictalurid) in catfish, and (2) coldwater disease (causative agent, Flavobacterium psychrophilum) and furunculosis<br />

(causative agent, Aeromonas salmonicida) in freshwater-reared salmonids. It’s anticipated that Aquaflor ® will be approved for<br />

additional claims in the U. S., including use to control mortality due to F. columnare in freshwater-reared salmonids. Approvals<br />

were the result of contributions from several public data-generating partners, including the USFWS’s Aquatic Animal Drug<br />

Approval Partnership (AADAP) Program. The AADAP Program and their partners conducted seven controlled field effectiveness<br />

studies in support of current and future approvals for use of Aquaflor ® to control mortality due to common fish diseases<br />

in freshwater-reared salmonids.The field efficacy studies were conducted at hatcheries that experience recurring, somewhat<br />

predictable outbreaks of the diseases of concern (e.g., coldwater disease, furunculosis, columnaris disease). Studies comprised<br />

a short acclimation period, a 10-d treatment period, and a 14-d posttreatment period. Results from each study showed that mean<br />

cumulative mortality at the end of the posttreatment period was significantly lower (P < 0.05) in treated tanks than in control<br />

tanks and that the concentration of florfenicol in feed was within ±20% of the target concentration.<br />

Table 1. Mean percent cumulative<br />

mortality (MCM) in treated and control<br />

tanks at the end of each field<br />

effectiveness study. Note, Fur =<br />

furunculsis; CWD = coldwater disease;<br />

col = columnaris.<br />

Fish<br />

species Disease<br />

MCM<br />

treated<br />

(%)<br />

MCM<br />

control<br />

(%)<br />

Coho Fur 11.1 30.3<br />

Chinook Fur 16.2 94.4<br />

Coho Fur 17.4 30.0<br />

Steelhead CWD 2.0 5.0<br />

Cutthroat CWD 75.0 94.0<br />

Coho Col 47.3 66.7<br />

Rainbows Col <strong>18</strong>.4 30.4<br />

a<br />

P-value = 0.0551<br />

a

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!